Extensive Arterial Thrombus Following Discharge after a Covid-19 Infection

Baştopçu, Murat

doi:10.1016/j.avsg.2020.11.008

Cited by 4 publications

(2 citation statements)

References 15 publications

(20 reference statements)

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Arterial thrombosis occurring in patients 2–3 weeks after recovery has been recently reported. 8 ) This is due to the continuation of the pro thrombotic state even after recovery. This raises the question of extended prophylaxis in these patients.…”

Section: Discussionmentioning

confidence: 99%

Management of Acute Limb Ischaemia Due to COVID-19 Induced Arterial Thrombosis: A Multi-Centre Indian Experience

Natarajan

Jagan

Viruthagiri

et al. 2022

Annals of Vascular Diseases

View full text Add to dashboard Cite

Objective: To determine the outcomes following various surgical and medical treatments of Coronavirus disease 2019 (COVID-19) induced acute limb ischaemia. Methods: A retrospective study of patients presenting with COVID induced arterial ischaemia in three hospitals from Southern India during the months of May 2020 to August 2021 was undertaken. These patients were managed by either thrombectomy, primary bypass, thrombolysis, anticoagulation or primary amputation based on the stage of ischaemia and the severity of COVID. Results: A total of 67 limbs in 59 patients were analysed. The average time to intervention was 15 days. Upper limb involvement was seen in 16 and lower limb in 51 limbs. Of the 67 limbs, 39 (58.2%) were treated by open surgical revascularisation, 5 (7.4%) by catheter directed lysis, 17 (25.3%) were managed conservatively and 6 (8.9%) underwent primary amputation. Successful revascularisation could be carried out in 88.6% of patients. A limb salvage rate of 80.6% was achieved in these patients with a re-intervention rate of 13.6%. Major amputation rate was 14.92% and mortality was 13.56%. Conclusion: Limb ischaemia after COVID can be safely managed by open thrombectomy or bypass. Similar rates of limb salvage as in non-COVID acute limb ischaemia can be obtained.

show abstract

Section: Discussionmentioning

confidence: 99%

Management of Acute Limb Ischaemia Due to COVID-19 Induced Arterial Thrombosis: A Multi-Centre Indian Experience

Natarajan

Jagan

Viruthagiri

et al. 2022

Annals of Vascular Diseases

View full text Add to dashboard Cite

show abstract

“…The novel coronavirus infection (COVID-19) can be associated with coagulopathy, which may cause thromboembolic events ( 1 ). The COVID-19 disease is an emerging threat due to the risk of thrombosis in microvascular, venous, and arterial beds.…”

Section: Introductionmentioning

confidence: 99%

Acute upper limb ischemia in a patient with COVID-19: A case report

Nasab

Heidarzadeh

Yavari

et al. 2021

Annals of Vascular Surgery

View full text Add to dashboard Cite

The novel pandemic of coronavirus infection (COVID-19) has been linked with coagulopathy and thromboembolic events, causing limb loss and finally death. The present report describes a case of upper limb ischemia in a patient with COVID-19 infection, who lacked conventional risk factors for acute limb ischemia (ALI). An 83-year-old man with intraluminal thrombus and the occlusion of the axillary and brachial arteries, ceasing blood supply to the distal part of the body, was tested positive for the COVID-19 infection. The patient received therapeutic anticoagulation and underwent open thromboembolectomy, which failed to save the patient's life. The link between COVID-19 and thromboembolism remains unknown and needs further studies to be disclosed.

show abstract

Long COVID, a comprehensive systematic scoping review

et al. 2021

View full text Add to dashboard Cite

Purpose To find out what is known from literature about Long COVID until January 30, 2021. Methods We undertook a four-step search with no language restriction. A preliminary search was made to identify the keywords. A search strategy of all electronic databases resulted in 66 eligible studies. A forward and backward search of the references and citations resulted in additional 54 publications. Non-English language articles were translated using Google Translate. We conducted our scoping review based on the PRISMA-ScR Checklist. Results Of 120 papers, we found only one randomized clinical trial. Of the 67 original studies, 22 were cohort, and 28 were cross-sectional studies. Of the total 120 publications, 49.1% focused on signs and symptoms, 23.3% on management, and 10.8% on pathophysiology. Ten publications focused on imaging studies. The results are also presented extensively in a narrative synthesis in separated sections (nomenclature, diagnosis, pathophysiology, risk factors, signs/symptoms, management). Conclusions The controversies in its definition have impaired proper recognition and management. The predominant symptoms were: fatigue, breathlessness, arthralgia, sleep difficulties, and chest pain. Recent reports also point to the risk of long-term sequela with cutaneous, respiratory, cardiovascular, musculoskeletal, mental health, neurologic, and renal involvement in those who survive the acute phase of the illness. Supplementary Information The online version contains supplementary material available at 10.1007/s15010-021-01666-x.

show abstract

Extensive Arterial Thrombus Following Discharge after a Covid-19 Infection

Cited by 4 publications

References 15 publications

Management of Acute Limb Ischaemia Due to COVID-19 Induced Arterial Thrombosis: A Multi-Centre Indian Experience

Management of Acute Limb Ischaemia Due to COVID-19 Induced Arterial Thrombosis: A Multi-Centre Indian Experience

Acute upper limb ischemia in a patient with COVID-19: A case report

Long COVID, a comprehensive systematic scoping review

Contact Info

Product

Resources

About